+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Vaccines Market 2022-2026

  • ID: 4855486
  • Report
  • April 2022
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • Bavarian Nordic AS
  • CSL Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Novavax Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the vaccines market and it is poised to grow by $28.28 bn during 2022-2026, accelerating at a CAGR of 4.13% during the forecast period. The report on the vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased funding for vaccine development and new vaccine launches, approval of vaccines and a strong pipeline, and increasing use of adjuvants in vaccines.

The vaccine market analysis includes type segment and geographic landscape.

The vaccines market is segmented as below:


By Type

  • Prophylactic vaccines
  • Therapeutic vaccines

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the development of nanoparticle vaccines as one of the prime reasons driving the vaccine market growth during the next few years. Also, advancements in the vaccine delivery system and the impact of COVID-19 will lead to sizable demand in the market.

The report on the vaccines market covers the following areas:

  • Vaccines market sizing
  • Vaccines market forecast
  • Vaccines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccines market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson, and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE. Also, the vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • Bavarian Nordic AS
  • CSL Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Novavax Inc.

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Prophylactic vaccines - Market size and forecast 2021-2026
Exhibit 28: Chart on Prophylactic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibit 29: Data Table on Prophylactic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibit 30: Chart on Prophylactic vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Prophylactic vaccines - Year-over-year growth 2021-2026 (%)
5.4 Therapeutic vaccines - Market size and forecast 2021-2026
Exhibit 32: Chart on Therapeutic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibit 33: Data Table on Therapeutic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibit 34: Chart on Therapeutic vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Therapeutic vaccines - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ billion)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ billion)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ billion)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ billion)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Astellas Pharma Inc.
Exhibit 85: Astellas Pharma Inc. - Overview
Exhibit 86: Astellas Pharma Inc. - Product/Service
Exhibit 87: Astellas Pharma Inc. - Key news
Exhibit 88: Astellas Pharma Inc. - Key offerings
10.4 AstraZeneca Plc
Exhibit 89: AstraZeneca Plc - Overview
Exhibit 90: AstraZeneca Plc - Product/Service
Exhibit 91: AstraZeneca Plc - Key news
Exhibit 92: AstraZeneca Plc - Key offerings
10.5 Bavarian Nordic AS
Exhibit 93: Bavarian Nordic AS - Overview
Exhibit 94: Bavarian Nordic AS - Product/Service
Exhibit 95: Bavarian Nordic AS - Key news
Exhibit 96: Bavarian Nordic AS - Key offerings
10.6 Bharat Biotech Ltd.
Exhibit 97: Bharat Biotech Ltd. - Overview
Exhibit 98: Bharat Biotech Ltd. - Product/Service
Exhibit 99: Bharat Biotech Ltd. - Key news
Exhibit 100: Bharat Biotech Ltd. - Key offerings
10.7 BrightPath Biotherapeutics Co. Ltd.
Exhibit 101: BrightPath Biotherapeutics Co. Ltd. - Overview
Exhibit 102: BrightPath Biotherapeutics Co. Ltd. - Product/Service
Exhibit 103: BrightPath Biotherapeutics Co. Ltd. - Key offerings
10.8 CSL Ltd.
Exhibit 104: CSL Ltd. - Overview
Exhibit 105: CSL Ltd. - Business segments
Exhibit 106: CSL Ltd. - Key news
Exhibit 107: CSL Ltd. - Key offerings
Exhibit 108: CSL Ltd. - Segment focus
10.9 Daiichi Sankyo Co. Ltd.
Exhibit 109: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 110: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 111: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 112: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 113: Daiichi Sankyo Co. Ltd. - Segment focus
10.10 Emergent BioSolutions Inc.
Exhibit 114: Emergent BioSolutions Inc. - Overview
Exhibit 115: Emergent BioSolutions Inc. - Product/Service
Exhibit 116: Emergent BioSolutions Inc. - Key news
Exhibit 117: Emergent BioSolutions Inc. - Key offerings
10.11 GlaxoSmithKline Plc
Exhibit 118: GlaxoSmithKline Plc - Overview
Exhibit 119: GlaxoSmithKline Plc - Business segments
Exhibit 120: GlaxoSmithKline Plc - Key news
Exhibit 121: GlaxoSmithKline Plc - Key offerings
Exhibit 122: GlaxoSmithKline Plc - Segment focus
10.12 Gradalis Inc.
Exhibit 123: Gradalis Inc. - Overview
Exhibit 124: Gradalis Inc. - Product/Service
Exhibit 125: Gradalis Inc. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Type - Market share 2021-2026 (%)
Exhibits 25: Data Table on Type - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Type
Exhibits 27: Data Table on Comparison by Type
Exhibits 28: Chart on Prophylactic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibits 29: Data Table on Prophylactic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibits 30: Chart on Prophylactic vaccines - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Prophylactic vaccines - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Therapeutic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibits 33: Data Table on Therapeutic vaccines - Market size and forecast 2021-2026 ($ billion)
Exhibits 34: Chart on Therapeutic vaccines - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Therapeutic vaccines - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Type ($ billion)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits 63: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibits 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits 67: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibits 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits 71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibits 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on France - Market size and forecast 2021-2026 ($ billion)
Exhibits 75: Data Table on France - Market size and forecast 2021-2026 ($ billion)
Exhibits 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ billion)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: Astellas Pharma Inc. - Overview
Exhibits 86: Astellas Pharma Inc. - Product/Service
Exhibits 87: Astellas Pharma Inc. - Key news
Exhibits 88: Astellas Pharma Inc. - Key offerings
Exhibits 89: AstraZeneca Plc - Overview
Exhibits 90: AstraZeneca Plc - Product/Service
Exhibits 91: AstraZeneca Plc - Key news
Exhibits 92: AstraZeneca Plc - Key offerings
Exhibits 93: Bavarian Nordic AS - Overview
Exhibits 94: Bavarian Nordic AS - Product/Service
Exhibits 95: Bavarian Nordic AS - Key news
Exhibits 96: Bavarian Nordic AS - Key offerings
Exhibits 97: Bharat Biotech Ltd. - Overview
Exhibits 98: Bharat Biotech Ltd. - Product/Service
Exhibits 99: Bharat Biotech Ltd. - Key news
Exhibits 100: Bharat Biotech Ltd. - Key offerings
Exhibits 101: BrightPath Biotherapeutics Co. Ltd. - Overview
Exhibits 102: BrightPath Biotherapeutics Co. Ltd. - Product/Service
Exhibits 103: BrightPath Biotherapeutics Co. Ltd. - Key offerings
Exhibits 104: CSL Ltd. - Overview
Exhibits 105: CSL Ltd. - Business segments
Exhibits 106: CSL Ltd. - Key news
Exhibits 107: CSL Ltd. - Key offerings
Exhibits 108: CSL Ltd. - Segment focus
Exhibits 109: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 110: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits 111: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 112: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 113: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits 114: Emergent BioSolutions Inc. - Overview
Exhibits 115: Emergent BioSolutions Inc. - Product/Service
Exhibits 116: Emergent BioSolutions Inc. - Key news
Exhibits 117: Emergent BioSolutions Inc. - Key offerings
Exhibits 118: GlaxoSmithKline Plc - Overview
Exhibits 119: GlaxoSmithKline Plc - Business segments
Exhibits 120: GlaxoSmithKline Plc - Key news
Exhibits 121: GlaxoSmithKline Plc - Key offerings
Exhibits 122: GlaxoSmithKline Plc - Segment focus
Exhibits 123: Gradalis Inc. - Overview
Exhibits 124: Gradalis Inc. - Product/Service
Exhibits 125: Gradalis Inc. - Key offerings
Exhibits 126: Inclusions checklist
Exhibits 127: Exclusions checklist
Exhibits 128: Currency conversion rates for US$
Exhibits 129: Research methodology
Exhibits 130: Validation techniques employed for market sizing
Exhibits 131: Information sources
Exhibits 132: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • Bavarian Nordic AS
  • CSL Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Novavax Inc.
The publisher recognizes the following companies as the key players in the global vaccines market: Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson, and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the development of nanoparticle vaccines."

According to the report, one of the major drivers for this market is the increased funding for vaccine development and new vaccine launches.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • BrightPath Biotherapeutics Co. Ltd.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Gradalis Inc.
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Mitsubishi Chemical Holdings Corp.
  • Novavax Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva SE
Note: Product cover images may vary from those shown